Beckman Coulter Life Sciences Acquires Blue Ocean Biomedical
Beckman Coulter Life Sciences (Indianapolis, Indiana) has acquired Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents.
Beckman Coulter Life Sciences (Indianapolis, Indiana) has acquired Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents. The transaction provides Beckman Coulter Life Sciences with low complexity analyzers that integrate automated sample preparation and directly address emerging flow cytometry market trends.
Driving growth through internal product development and through the acquisition of differentiated businesses and technologies is a core strategy of Beckman Coulter Life Sciences. Blue Ocean Biomedical products complement the company’s cytometry portfolio with instruments based on a “sample in, result out” approach that represents a fundamental change in the routine clinical analysis sector.
The systems and reagents are currently not available in the U.S.; they are available for distribution in the European Union only.
Assessing Safety of Medications During Pregnancy and Breastfeeding with LC–MS/MS
Published: April 8th 2025 | Updated: April 8th 2025Researchers conducted a study on medications used in psychiatry and neurology during the perinatal period, assessing how antiepileptic drugs (AEDs) affect placental functions, including transport mechanisms, nutrient transport, and trophoblast differentiation. Several quantitative methods, such as those for antianxiety and hypnotic drugs, were established to evaluate the safety of pharmacotherapy during breastfeeding using liquid chromatography-tandem mass spectrometry (LC–MS/MS).
